Therefore, CyCl induces apoptosis by participating in NF-κB signaling in CRC cells, and Nrf2 may be a potential drug target to treat CRC by regulating the Nrf2/HO-1/NQO1 pathway (49). The gene discussed is NQO1; the disease is colorectal carcinoma.